title: Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation.
abstract: Hypothalamic-pituitary-adrenal (HPA) axis responsiveness differs physiologically and pharmacologically between the sexes (sexual diergism). Central nicotinic receptors modulate this endocrine axis. Previous studies have established that nicotine (NIC) stimulates the HPA axis; however, only male animals have been used. We have demonstrated that plasma arginine vasopressin (AVP) and adrenocorticotropic hormone (ACTH) concentrations showed greater responsiveness in male than in female rats pretreated with scopolamine (SCOP), a muscarinic antagonist, followed by physostigmine (PHYSO), an acetylcholinesterase inhibitor. These results suggest that the SCOP + PHYSO effects may have resulted from an indirect nicotinic effect caused by increased synaptic acetylcholine with simultaneous muscarinic antagonism. In the present study, we investigated nicotinic cholinergic influences on HPA axis activity in male and female rats by administering NIC (0, 0.03, 0.1, 0.3, or 0.5 mg/kg) and determining plasma AVP, ACTH, and corticosterone (CORT) responses. Male rats had a significantly greater, dose-related AVP response to NIC than did females. In contrast, female rats had significantly greater, dose-related ACTH and CORT responses to NIC than did males. Hormone responses following NIC were similar to hormone responses following SCOP + PHYSO. These results suggest nicotinic receptors influence the HPA axis differentially in male and female rats.
authors.affiliation: Center for Neurosciences Research, Allegheny-Singer Research Institute, Allegheny General Hospital, Pittsburgh, PA 15212, USA. mrhodes@wpahs.org
authors.forename: M E
authors.initials: ME
authors.lastname: Rhodes
authors.forename: S M
authors.initials: SM
authors.lastname: O'Toole
authors.forename: R K
authors.initials: RK
authors.lastname: Czambel
authors.forename: R T
authors.initials: RT
authors.lastname: Rubin
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood / Q000187:drug effects; D000818:Animals; D001127:Arginine Vasopressin / Q000097:blood / Q000187:drug effects / Q000378:metabolism; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D003348:Cortisone / Q000097:blood; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011978:Receptors, Nicotinic / Q000187:drug effects* / Q000378:metabolism; D012727:Sex Characteristics
chemical_list: D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D001127:Arginine Vasopressin; D009538:Nicotine; D000324:Adrenocorticotropic Hormone; D003348:Cortisone